Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Receivables (2023 - 2025)

Historic Receivables for Cannabis Bioscience International Holdings (CBIH) over the last 6 years, with Q3 2025 value amounting to $18121.0.

  • Cannabis Bioscience International Holdings' Receivables rose 550.19% to $18121.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $18121.0, marking a year-over-year increase of 550.19%. This contributed to the annual value of $15535.0 for FY2025, which is 2286.11% down from last year.
  • According to the latest figures from Q3 2025, Cannabis Bioscience International Holdings' Receivables is $18121.0, which was up 550.19% from $15535.0 recorded in Q2 2025.
  • Over the past 5 years, Cannabis Bioscience International Holdings' Receivables peaked at $20139.0 during Q2 2024, and registered a low of $2640.0 during Q1 2025.
  • Its 3-year average for Receivables is $14036.2, with a median of $17041.0 in 2024.
  • Per our database at Business Quant, Cannabis Bioscience International Holdings' Receivables surged by 10238.17% in 2024 and then crashed by 8450.8% in 2025.
  • Over the past 3 years, Cannabis Bioscience International Holdings' Receivables (Quarter) stood at $19403.0 in 2023, then tumbled by 67.43% to $6320.0 in 2024, then soared by 186.72% to $18121.0 in 2025.
  • Its last three reported values are $18121.0 in Q3 2025, $15535.0 for Q2 2025, and $2640.0 during Q1 2025.